Company profilePharmaceutical#1305 of 1,318 in Pakistan1 DRAP alert

Csl Behring

Pharmaceutical company · 1 brands · 2 molecules

Ranked #5 of 6 companies in Blood Substitutes And Plasma Protein Fractions (Hospital Solution)

1 registered products 2 pharmaceutical brands 2 distinct molecules 1 DRAP alert

Company overview

registered products

pharmaceutical brands

distinct molecules

therapeutic classes

DRAP alerts

Csl Behring is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 1 product registration across 2 distinct molecules. Its portfolio is concentrated in Blood Substitutes And Plasma Protein Fractions (Hospital Solution). DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Albumin1 brand

Human1 brand

Therapeutic classes

Conditions treated

Price band (DRAP official ceilings)

Registered products priced by source

Servaid2 products · Rs 6,630 – Rs 12,400

Median across source: Rs 9,515

Regulatory record

1 alert in the DRAP feed we track.

Recall Alert: Drug Product; Human Albumin 20% 100mL (Batch/Lot # C236821P02) Manufactured

2022-10-07

Competitive set

Companies whose registered portfolio overlaps most with this one.

NABIQASIM INDUSTRIES (PVT) LTD.2 shared molecules

S. EJAZUDDIN & COMPANY2 shared molecules

TALECRIS/POPULAR2 shared molecules

GETZ PHARMA PAKISTAN (PVT) LTD.1 shared molecules

ELI LILLY PAKISTAN (PVT) LTD.1 shared molecules

NOVO NORDISK SCIENTIFIC OFFICE1 shared molecules

Novo Nordisk Pharma (Pvt.) Ltd.1 shared molecules

Biotest1 shared molecules

Get the full profile for Csl

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included